Down Syndrome Phenotypes: The Consequences of Chromosomal Imbalance

Autor: Korenberg, J. R., Schipper, R., Sun, Z., Gonsky, R., Gerwehr, S., Carpenter, N., Daumer, C., Dignan, P., Disteche, C., Graham,, J. M., Hudgins, L., McGillivray, B., Miyazaki, K., Ogasawara, N., Park, J. P., Pagon, R., Pueschel, S., Sack, G., Say, B., Schuffenhauer, S., Soukup, S., Yamanaka, T.

Publikováno v: Proceedings of the National Academy of Sciences of the United States of America, 1994 May . 91(11), 4997-5001.

Externí odkaz: https://www.jstor.org/stable/2364898

Diagnostic and therapeutic potential of RNASET2 in Crohn's disease: Disease-risk polymorphism modulates allelic-imbalance in expression and circulating protein levels and recombinant-RNASET2 attenuates pro-inflammatory cytokine secretion.

Autor: Biener-Ramanujan E; Inflammatory Bowel & Immunobiology Research Institute, Cedars-Sinai, Los Angeles, CA, United States., Rosier F; Inflammatory Bowel & Immunobiology Research Institute, Cedars-Sinai, Los Angeles, CA, United States., Coetzee SG; Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, United States., McGovern DDP; Inflammatory Bowel & Immunobiology Research Institute, Cedars-Sinai, Los Angeles, CA, United States., Hazelett D; Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, United States., Targan SR; Inflammatory Bowel & Immunobiology Research Institute, Cedars-Sinai, Los Angeles, CA, United States., Gonsky R; Inflammatory Bowel & Immunobiology Research Institute, Cedars-Sinai, Los Angeles, CA, United States.

Publikováno v: Frontiers in immunology [Front Immunol] 2022 Nov 16; Vol. 13, pp. 999155. Date of Electronic Publication: 2022 Nov 16 (Print Publication: 2022).

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Direct signaling of TL1A-DR3 on fibroblasts induces intestinal fibrosis in vivo.

Autor: Jacob N; Vatche and Tamar Manoukian Division of Digestive Diseases, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, 10945 Le Conte Ave., Suite 2114, Los Angeles, CA, 90095, USA. njacob@mednet.ucla.edu.; Division of Gastroenterology, Hepatology and Parenteral Nutrition, VA Greater Los Angeles Healthcare System, Los Angeles, CA, 90073, USA. njacob@mednet.ucla.edu., Kumagai K; F. Widjaja Foundation, Cedars-Sinai Medical Center, Inflammatory Bowel & Immunobiology Research Institute, Los Angeles, CA, 90048, USA., Abraham JP; F. Widjaja Foundation, Cedars-Sinai Medical Center, Inflammatory Bowel & Immunobiology Research Institute, Los Angeles, CA, 90048, USA., Shimodaira Y; F. Widjaja Foundation, Cedars-Sinai Medical Center, Inflammatory Bowel & Immunobiology Research Institute, Los Angeles, CA, 90048, USA., Ye Y; F. Widjaja Foundation, Cedars-Sinai Medical Center, Inflammatory Bowel & Immunobiology Research Institute, Los Angeles, CA, 90048, USA., Luu J; F. Widjaja Foundation, Cedars-Sinai Medical Center, Inflammatory Bowel & Immunobiology Research Institute, Los Angeles, CA, 90048, USA., Blackwood AY; F. Widjaja Foundation, Cedars-Sinai Medical Center, Inflammatory Bowel & Immunobiology Research Institute, Los Angeles, CA, 90048, USA., Castanon SL; F. Widjaja Foundation, Cedars-Sinai Medical Center, Inflammatory Bowel & Immunobiology Research Institute, Los Angeles, CA, 90048, USA., Stamps DT; F. Widjaja Foundation, Cedars-Sinai Medical Center, Inflammatory Bowel & Immunobiology Research Institute, Los Angeles, CA, 90048, USA., Thomas LS; F. Widjaja Foundation, Cedars-Sinai Medical Center, Inflammatory Bowel & Immunobiology Research Institute, Los Angeles, CA, 90048, USA., Gonsky R; F. Widjaja Foundation, Cedars-Sinai Medical Center, Inflammatory Bowel & Immunobiology Research Institute, Los Angeles, CA, 90048, USA., Shih DQ; F. Widjaja Foundation, Cedars-Sinai Medical Center, Inflammatory Bowel & Immunobiology Research Institute, Los Angeles, CA, 90048, USA., Michelsen KS; F. Widjaja Foundation, Cedars-Sinai Medical Center, Inflammatory Bowel & Immunobiology Research Institute, Los Angeles, CA, 90048, USA., Targan SR; F. Widjaja Foundation, Cedars-Sinai Medical Center, Inflammatory Bowel & Immunobiology Research Institute, Los Angeles, CA, 90048, USA.

Publikováno v: Scientific reports [Sci Rep] 2020 Oct 23; Vol. 10 (1), pp. 18189. Date of Electronic Publication: 2020 Oct 23.

Involvement of protein kinase Cepsilon (PKCepsilon) in thyroid cell death. A truncated chimeric PKCepsilon cloned from a thyroid cancer cell line protects thyroid cells from apoptosis

Autor: Knauf, Ja, Elisei, Rossella, Mochly Rosen, D, Liron, T, Chen, Xn, Gonsky, R, Korenberg, Jr, Fagin, Ja

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3728::3020415515a7bc31403019cbfefa5d9b
http://hdl.handle.net/11568/170620